These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 3994344
1. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. King CH, Creger RJ, Ellner JJ. Antimicrob Agents Chemother; 1985 Mar; 27(3):285-90. PubMed ID: 3994344 [Abstract] [Full Text] [Related]
2. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance. Lim AK, Mathanasenarajah G, Larmour I. Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282 [Abstract] [Full Text] [Related]
3. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Schentag JJ, Plaut ME, Cerra FB. Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770 [Abstract] [Full Text] [Related]
4. Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens. Pancorbo S, Compty C, Heissler J. Biopharm Drug Dispos; 1982 May; 3(1):83-8. PubMed ID: 7082782 [Abstract] [Full Text] [Related]
5. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin. Bauer LA, Blouin RA. Eur J Clin Pharmacol; 1983 May; 24(5):639-42. PubMed ID: 6873143 [Abstract] [Full Text] [Related]
9. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs. Chung M, Parravicini L, Assael BM, Cavanna G, Radwanski E, Symchowicz S. Antimicrob Agents Chemother; 1982 Dec; 22(6):1017-21. PubMed ID: 7159067 [Abstract] [Full Text] [Related]
10. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis. Mann HJ, Canafax DM, Cipolle RJ, Daniels CE, Zaske DE, Warwick WJ. Pediatr Pulmonol; 1985 Dec; 1(5):238-43. PubMed ID: 4069813 [Abstract] [Full Text] [Related]
11. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin. Lode H, Kemmerich B, Koeppe P. Antimicrob Agents Chemother; 1975 Oct; 8(4):396-401. PubMed ID: 1103722 [Abstract] [Full Text] [Related]
12. Gentamicin and tobramycin penetration into burn eschar. Pharmacokinetics and microbiological effects. Polk RE, Mayhall CG, Smith J, Hall G, Kline BJ, Swensson E, Haynes BW. Arch Surg; 1983 Mar; 118(3):295-302. PubMed ID: 6824430 [Abstract] [Full Text] [Related]
13. Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance. Vozeh S, Spring P, Wenk M, Follath F. Br J Clin Pharmacol; 1979 Jun; 7(6):629-31. PubMed ID: 465287 [No Abstract] [Full Text] [Related]
14. Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function. Lau A, Lee M, Flascha S, Prasad R, Sharifi R. Antimicrob Agents Chemother; 1983 Oct; 24(4):533-7. PubMed ID: 6651279 [Abstract] [Full Text] [Related]
18. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration. Chuk AC, Saeed F, Kousar N, Burrill S, Barns B, Rickrode G, Fu J, Katrych O, Saunders-Hao P, Block C, Lahey T. Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of gentamicin in the juvenile dog. Riviere JE, Coppoc GL. Am J Vet Res; 1981 Sep; 42(9):1621-3. PubMed ID: 7325472 [Abstract] [Full Text] [Related]